Global Medical PP Infusion Bottle Market Research Report 2022

The polypropylene infusion bottle is not easy to break, has good toughness and good mechanical strength, and is easy to transport and use; the sealing performance of the bottle mouth is good, and the welding process is adopted, and there is no leakage of glass bottle infusion caps; the chemical properties are stable, the drug compatibility is good, and the insolubility The particles are 5 times less than the glass bottle infusion; the biaxial stretching process is more transparent than the transparent plastic bottle produced by the extrusion blow method, and the outer cover combined cover with the inner cover plate, isoprene rubber pad and easy-pull ring is used to ensure the sealing Good performance, moderate perforation force, good needle stagnation, can be pressed down, will not drop chips during the puncture process, and the pulling force of the easy-to-pull ring is moderate; when rapid infusion is required, it is suitable for For extrusion infusion, the extrusion port of the container can withstand a pressure of more than 0.5Pa; under the same cleanliness as drug production, self-produced and self-used plastic bottles can ensure no pollution, and the manufacturing process is more in line with GMP requirements.
Due to the COVID-19 pandemic, the global Medical PP Infusion Bottle market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Medical PP Infusion Bottle market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Medical PP Infusion Bottle landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Below 50 ml accounting for % of the Medical PP Infusion Bottle global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Medical PP Infusion Bottle include SSY Group Limited, Gil Pack, Dai Han Pharm, Ilhaplast and Fresenius KABI, etc. In terms of revenue, the global 3 largest players have a % market share of Medical PP Infusion Bottle in 2021.
This report focuses on Medical PP Infusion Bottle volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medical PP Infusion Bottle market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Medical PP Infusion Bottle Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Below 50 ml
50 ml-100 ml
Above 100 ml
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
SSY Group Limited
Gil Pack
Dai Han Pharm
Ilhaplast
Fresenius KABI

Frequently Asked Questions